Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc.

Contact: Kathleen Baddley

734-412-5789

Esperion

Esperion Therapeutics, Inc.

Contact: Brooke Smith

703-407-2500

Esperion

Esperion Therapeutics is The Lipid Management Company. Our products, NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets are oral, non-statins used with diet & maximally tolerated statins to treat adults with HeFH or ASCVD needing added LDL-C lowering. The effect on cardiovascular morbidity/mortality has not been determined. Contraindication for NEXLIZET is known hypersensitivity to ezetimibe. Warnings: Both increase risk of hyperuricemia & tendon rupture. www.nexletolhcp.com/risk